BRIEF

on LR Health & Beauty SE (isin : NO0013149658)

LR Health & Beauty SE Reports Profitable Growth in Q1 2025

LR Health & Beauty SE announced a profitable start to 2025 with a 2% increase in sales, reaching EUR 74 million. The company also reported a 20.5% rise in EBITDA, amounting to EUR 7.4 million. Despite a challenging consumer atmosphere in Europe, the company’s strategic growth initiatives, including digitalisation and process optimisation, have driven efficiency and profitability.

The activation of a modern logistics centre at Ahlen and advancements in IT infrastructure have propelled the company’s efficiency. LR Health & Beauty's ongoing digital transformation appears to be a pivotal factor in its growth strategy. Expectations for stable to moderately rising sales with significantly higher EBITDA in 2025 have been maintained.

The company plans to harness first-quarter momentum with upcoming product launches and seasonal sales initiatives to continue its growth trajectory throughout the year.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all LR Health & Beauty SE news